Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03478462
Title Dose Escalation Study of CLR 131 in Children and Adolescents With Relapsed or Refractory Malignant Brain Cancer, Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cellectar Biosciences, Inc.
Indications

neuroblastoma

lymphoma

Advanced Solid Tumor

brain cancer

sarcoma

Therapies

CLR 131

Age Groups: adult | child
Covered Countries USA | CAN


No variant requirements are available.